Concepedia

Christopher B. Fox

CB

Statistics

Publications

98

Citations

5.3K

H-Index

44

Active since

1998

Affiliations

Infectious Disease Research Institute(Current)

University of Washington

Duke University

Duke Medical Center

National Institute of Allergy and Infectious Diseases

Christopher B. Fox is an author at Infectious Disease Research Institute specializing in immunology, vaccinology, and vaccine immunology.

ORCID

Publications per year

1998–2024

98

Publications

98

Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant

Rhea N. Coler, Sylvie Bertholet, Magdalini Moutaftsi et al. · PLoS ONE · 2011 · 311 citations · Full text

, , +16

Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses

Kevin O. Saunders, Esther Lee, Robert Parks et al. · Nature · 2021 · 276 citations · Full text

, , +14

Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens

Niels Peter Hell Knudsen, Anja Weinreich Olsen, Cecilia Buonsanti et al. · Scientific Reports · 2016 · 231 citations · Full text

, , +17

A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika

Jesse H. Erasmus, Amit P. Khandhar, Jeff Guderian et al. · Molecular Therapy · 2018 · 169 citations · Full text

, , +17

3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope–specific plasma cells and humoral immunity in nonhuman primates

Sudhir Pai Kasturi, Mohammed Ata Ur Rasheed, Colin Havenar‐Daughton et al. · Science Immunology · 2020 · 151 citations · Full text

, , +15

1–5 of 98